GEH200520GEH200521GE-269-004GE Healthcaresolid tumorsUniversity Medical Center GroningenVanderbilt Universitycancer therapy
…racers, enabling repeat imaging sessions. The 2 mg mass dose of GEH200520 was selected for Part B of both studies, where GE-269-001 will …